Supplemental Fosfomycin and/or Steroids that Reduce Cisplatin-Induced Nephrotoxicity
- 1 January 1988
- journal article
- research article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 295 (1) , 6-10
- https://doi.org/10.1097/00000441-198801000-00003
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- β-Galactosidase, β-glucosidase and N-acetyl-β-glucosaminidase in human kidneyPublished by Elsevier ,2003
- Protective effect of fosfomycin on the experimental nephrotoxicity induced by dibekacin.Journal of Pharmacobio-Dynamics, 1982
- The use of urinary N-acetyl-β-glucosaminidase in human renal toxicology II. Elevation in human excretion after aspirin and sodium salicylateToxicology and Applied Pharmacology, 1979
- Cisplatin (cis-diamminedichloroplatinum II)Cancer Treatment Reviews, 1979
- Acute interstitial nephritis due to methicillinThe American Journal of Medicine, 1978
- Platinum nephrotoxicityThe American Journal of Medicine, 1978
- The renal pathology in clinical trials of Cis-platinum (II) diamminedichlorideCancer, 1977
- Antileukaemic and Nephrotoxic Properties of Platinum CompoundsNature, 1971
- THE LOCALIZATION OF N-ACETYL-β-GLUCOSAMINIDASE IN TISSUESJournal of Histochemistry & Cytochemistry, 1961
- ON THE COLORIMETRIC DETERMINATION OF CREATININE BY THE JAFFE REACTIONJournal of Biological Chemistry, 1945